← Back to headlines
UBS Maintains Positive Outlook on AstraZeneca Ahead of Q2 Results
UBS analysts have expressed continued optimism regarding AstraZeneca's financial performance, anticipating favorable results ahead of the pharmaceutical company's second-quarter earnings announcement.
13 Jul, 11:31 — 13 Jul, 11:31
Sources
Showing 1 of 1 sources
